Lipid Controls
Avanti Polar Lipids 18:1 DGS-NTA(CO) 10MG
1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (Cobalt salt) 10mg
Avanti Polar Lipids DOTAP, 25MG
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt). 132172-61-3
(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC | 1mg | 779524049](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502460679.PNG-250.jpg)
eMolecules 62600-81-1 | 1-Palmitoyl-2-Oleoyl-sn-glycero-3-PA (solution in chloroform) | Broadpharm | MFCD05864230 | 674.941 | C37H71O8P | 0.000 | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC | 1mg | 779524049
1-Palmitoyl-2-Oleoyl-sn-glycero-3-PA (solution in chloroform) | Broadpharm | 62600-81-1 | MFCD05864230 | 674.941 | C37H71O8P | 0.000 | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC | 1mg | 779524049
Cayman Chemical DLin-MC3-DMA, Purity: ≥95%, CAS: 1224606-06-7, 25 mg
An ionizable cationic lipid (apparent pKa = 6.44); has been used in the generation of lipid nanoparticles (LNPs) encapsulating siRNA, mRNA, or plasmid DNA for use in vitro and in vivo; LNPs containing DLin-MC3-DMA accumulate in the muscle and non-draining lymph nodes after intramuscular administration and in the spleen after intravenous administration in mice; LNPs containing DLin-MC3-DMA and encapsulating F7 siRNA reduce hepatic and plasma Factor VII levels in mice without inducing liver toxicity
Avanti Polar Lipids CARDIOLIPIN
1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol (sodium salt). 115404-77-8
Avanti Polar Lipids 1,2-DIHEPTANLYL-SN-GLYCERO/1GR
1,2-diheptanoyl-sn-glycero-3-phosphocholine. 39036-04-9
Avanti Polar Lipids 16:1 (Δ9-Cis) PC, 4724-96-3, MFCD00214374, chloroform, 25mg, 10mg/mL 2.5mL
Molecular Formula C40H76NO8P, Purity >99%, Formula Weight 730.007, Storage Temperature -20°C, 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine
Cayman Chemical 1,3-Distearoyl-2-Oleoyl Glycerol, Purity: ≥98%, CAS: 2846-04-0, 10 mg
A triacylglycerol; has been found in Kpangnana, Chinese tallow, and cocoa butters; increases the phagocytic function of reticulo-endothelial cells in mice at 5 and 10 mg per animal
Avanti Polar Lipids 3D-PHAD, Powder | 1699735-79-9 | 1 mg
3D-PHAD, Powder | Purity: >99% | Mol Wt: 1537.114 | 1699735-79-9 | 1 mg
Medchemexpress LLC Peg2000-c-dmg | 1443687-74-8 | 99.97% | C126H249NO52 | 100 MG
PEG2000-C-DMG is a pegylated lipid used in the preparation of Onpattro, an investigational RNAi therapeutic agent. Onpattro is hepatically directed and reduces the production of mutant and wild-type transthyretin by targeting the 3′ untranslated region of transthyretin mRNA.
- Pegylated lipid
- Used in the preparation of Onpattro
- Onpattro is an investigational RNAi therapeutic agent
- Onpattro reduces production of mutant and wild-type transthyretin
- Targets 3′ untranslated region of transthyretin mRNA
- Suitable for research use only
